title: Drug development strategies for salvage therapy: conflicts and solutions.
authors.affiliation: Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA. victor@sdac.harvard.edu
authors.forename: Victor
authors.initials: V
authors.lastname: De Gruttola
authors.forename: Charles
authors.initials: C
authors.lastname: Flexner
authors.forename: Jonathan
authors.initials: J
authors.lastname: Schapiro
authors.forename: Michael
authors.initials: M
authors.lastname: Hughes
authors.forename: Mark
authors.initials: M
authors.lastname: Van Der Laan
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Kuritzkes
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000941:ethics; D004334:Drug Administration Schedule; D032984:Ethics, Research; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D012107:Research Design; D016879:Salvage Therapy / Q000941:ethics
chemical_list: D019380:Anti-HIV Agents